Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), also known as Apo-
2 ligand (Apo2L), is a member of the TNF cytokine superfamily. By cross-linking TRAIL …

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand, or TRAIL, is a promising
anticancer agent as it can induce apoptosis in a wide range of cancers whilst generally …

Resistance to chemotherapeutic drugs is the major hindrance in the successful cancer
therapy. The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of …

Tumour necrosis factor-related apoptosis-inducing ligand or Apo2 ligand (TRAIL/Apo2L) is a
member of the tumour necrosis factor (TNF) superfamily of cytokines that induces apoptosis …

Simple Summary TRAIL is a death ligand cytokine, predominantly used by effector immune
cells to kill malignantly transformed cells. Since its discovery, TRAIL has attracted a lot of …

Since its discovery in 1995, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL),
a member of the tumor necrosis factor super family, has been under intense focus because …

Monoclonal antibodies (mAbs) are an important class of therapeutic agents approved for the
therapy of many types of malignancies. However, in certain cases applications of …

The tumor necrosis factor (TNF) ligand and cognate TNF receptor superfamilies constitute
an important regulatory axis that is pivotal for immune homeostasis and correct execution of …

Inducing apoptosis has become an important approach in the development of new anti-
cancer treatments. Tumour necrosis factor apoptosis inducing ligand (TRAIL) based …

Cytokines are key players in stimulating and regulating immune responses in physiological
and pathophysiological processes. Various cytokines have been approved for therapy of …